Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,148 | 13,700 | 11,836 | 12,034 | 24,016 |
| Marketable Securities | N/A | N/A | 0 | 2,089 | 2,061 |
| Receivables | 2,069 | 52 | 4,805 | 54 | 340 |
| TOTAL | $18,930 | $14,453 | $17,817 | $14,438 | $26,924 |
| Non-Current Assets | |||||
| PPE Net | 727 | 413 | 333 | 320 | 460 |
| TOTAL | $727 | $413 | $333 | $320 | $460 |
| Total Assets | $19,658 | $14,865 | $18,150 | $14,758 | $27,384 |
| Liabilities | |||||
| Current Liabilities | |||||
| Other current liabilities | 9,356 | 61 | N/A | N/A | N/A |
| TOTAL | $12,869 | $2,815 | $5,230 | $4,069 | $2,709 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 0 | 927 | 1,546 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 52 | 0 | 0 | 0 |
| TOTAL | $6,897 | $5,855 | $4,637 | $0 | $0 |
| Total Liabilities | $19,766 | $8,670 | $9,867 | $4,069 | $2,709 |
| Shareholders' Equity | |||||
| Common Shares | 311,078 | 285,193 | 271,710 | 262,322 | 261,325 |
| Retained earnings | -344,606 | -311,483 | -294,446 | -278,829 | -263,689 |
| Other shareholders' equity | 4,082 | 4,225 | 3,992 | 554 | 761 |
| TOTAL | $-108 | $6,195 | $8,284 | $10,690 | $24,674 |
| Total Liabilities And Equity | $19,658 | $14,865 | $18,150 | $14,758 | $27,384 |